Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by SizzlinSteakson Oct 12, 2017 10:32pm

159 Views

Post# 26807834

RE:RE:RE:RE:RE:Nasdaq applies to operate stock exchange in Canada

Why do you think TLT would get peanuts ($5 per share) with 100% success compared to KITE who was bought for $11.9 billion by Gilead and Medivation who was bought for $13.9 billion from Pfiser ....and we all know both these companies trials have plenty of issues.

Pull yourself together. We are worth HUNDREDS OF DOLLARS, not 5 dollars. Lets compare apples to apples. Not apples to peanuts.

pennyoilking wrote: We should have great news before the 23rd if Roger does his job. Otherwise, I guess the worst is waiting until the 23rd and then hearing about big pharma stepping in and TLT over $5 US

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025